Sara Reddington, MA, CCC-SLP | |
1701 Library Blvd Ste C, Greenwood, IN 46142-1567 | |
(317) 881-9923 | |
Not Available |
Full Name | Sara Reddington |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1701 Library Blvd Ste C, Greenwood, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023585320 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 46003177A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sara Reddington, MA, CCC-SLP 1433 N Pennsylvania St Apt 406, Indianapolis, IN 46202-4445 Ph: (812) 746-5413 | Sara Reddington, MA, CCC-SLP 1701 Library Blvd Ste C, Greenwood, IN 46142-1567 Ph: (317) 881-9923 |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from the combined results of two Phase 3 studies of PA32540, an antiplatelet therapy of enteric-coated (EC) and immediate-release omeprazole, in patients with previous cerebrovascular disease.
According to an Indonesian health ministry official, a 7-year-old Indonesian girl who died last week has tested positive for bird flu in local tests; the results have yet to be confirmed by a World Health Organisation-accredited laboratory in Hong Kong.
This advancement has the potential to significantly speed the development of new, improved therapies for diffuse large B cell lymphoma (DLBCL), the most common type of human B cell lymphoma. Human B cell lymphomas cause 85 percent of non-Hodgkin's lymphomas, the sixth leading cause of cancer deaths in the United States.
An Italian study featured in the March issue of The Journal of Nuclear Medicine demonstrates that a novel nuclear medicine imaging agent targeting copper accumulation in tumors can detect prostate cancer recurrence early in patients with biochemical relapse (rising prostate-specific antigen [PSA] level).
Amsterdam Molecular Therapeutics (AMT) Holding N.V. a leader in the field of human gene therapy, announced today that the U.S. Food and Drug Administration (FDA) has designated AMT-080, a gene therapy for Duchenne muscular dystrophy (DMD) as an orphan drug.
› Verified 8 days ago
Christina M Dulhanty, MA, CFY Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Library Blvd, Suite A, Greenwood, IN 46142 Phone: 317-881-9923 | |
Elizabeth Amos, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Library Blvd Ste A, Greenwood, IN 46142 Phone: 317-881-9923 | |
Carol A Bell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Library Blvd Ste A, Greenwood, IN 46142 Phone: 317-881-9923 | |
Kaylee Nicole Taylor, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 601 Library Park Dr Ste A, Greenwood, IN 46142 Phone: 317-881-9923 | |
Ms. Kaitlin Sims, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3000 S State Road 135 Ste 110, Greenwood, IN 46143 Phone: 317-497-6000 | |
Olivia O'dell, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2339 S State Road 135, Greenwood, IN 46143 Phone: 317-535-0422 |